Recognition of irrationality of fear and the diagnosis of social anxiety disorder and specific phobia in adults: Implications for criteria revision in DSM-5

2010 ◽  
Vol 27 (11) ◽  
pp. 1044-1049 ◽  
Author(s):  
Mark Zimmerman ◽  
Kristy Dalrymple ◽  
Iwona Chelminski ◽  
Diane Young ◽  
Janine N. Galione
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Specific Phobia ◽  
Dsm 5

scholarly journals Music performance anxiety and its anxiety correlates

2019 ◽  
Author(s):  
Anna Wiedemann ◽  
Daniel Vogel ◽  
Catharina Voss ◽  
Jana Hoyer
Keyword(s):  
Cluster Analysis ◽  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Graphical Model ◽  
Music Performance ◽  
Performance Anxiety ◽  
Separation Anxiety Disorder ◽  
Music Performance Anxiety ◽  
Dsm 5

Music performance anxiety (MPA) is considered a social anxiety disorder (SAD). Recent conceptualisations, however, challenge existing MPA definitions, distinguishing MPA from SAD. In this study, we aim to provide a systematic analysis of MPA interdependencies to other anxiety disorders through graphical modeling and cluster analysis. Participants were 82 music students (Mage=23.5 years, SD=3.4; 69.5% women) with the majority being vocal (30.5%), string (24.4%) or piano (19.5%) students. MPA was measured using the German version of the Kenny Music Performance Anxiety Inventory (K-MPAI). All participants were tested for anxiety-related symptoms using the disorder-specific anxiety measures of the DSM-5, including agoraphobia (AG), generalised anxiety disorder (GAD), panic disorder (PD), separation anxiety disorder (SEP), specific phobia (SP), social anxiety disorder (SAD) and illness anxiety disorder (ILL). We found no evidence of MPA being primarily connected to SAD, finding GAD acted as a full mediator between MPA and any other anxiety type. Our graphical model remained unchanged considering severe cases of MPA only (K-MPAI≥105). By means of cluster analysis, we identified two participant sub-groups of differing anxiety profiles. Participants with pathological anxiety consistently showed more severe MPA. Our findings suggest that GAD is the strongest predictor for MPA amongst all major DSM-5 anxiety types.

Modification of the medical exclusion criterion in DSM-5 social anxiety disorder: Comorbid obesity as an example

2017 ◽  
Vol 210 ◽  
pp. 230-236 ◽  
Author(s):  
Kristy L. Dalrymple ◽  
Emily Walsh ◽  
Lia Rosenstein ◽  
Iwona Chelminski ◽  
Mark Zimmerman
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Exclusion Criterion ◽  
Dsm 5

Pharmacological Treatments for Panic Disorder, Generalized Anxiety Disorder, Specific Phobia, and Social Anxiety Disorder

2015 ◽  
Author(s):  
Ryan J. Kimmel ◽  
Peter P. Roy-Byrne ◽  
Deborah S. Cowley
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Panic Disorder ◽  
Generalized Anxiety Disorder ◽  
Social Anxiety Disorder ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Specific Phobia ◽  
Generalized Anxiety ◽  
Pharmacological Treatments ◽  
First Line

Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for panic disorder based on their low rate of side effects, lack of dietary restrictions, and absence of tolerance. SSRIs and venlafaxine are attractive first-line treatments for social anxiety disorder. Pharmacological treatments of choice for generalized anxiety disorder are buspirone and antidepressants, including SSRIs and venlafaxine. Benzodiazepines, although effective for all these disorders, lack efficacy for comorbid depression and carry the risk of physiological dependence and withdrawal symptoms. Their greatest utility seems to be as an initial or adjunctive medication for patients with disabling symptoms requiring rapid relief and for those unable to tolerate other medications. Chronic treatment with benzodiazepines is generally safe and effective but should probably be reserved for patients nonresponsive or intolerant to other agents. Larger trials are necessary to determine whether pharmacological agents might be useful as monotherapies, or adjuncts to exposure psychotherapy, for specific phobia.

scholarly journals DSM-IV and DSM-5 social anxiety disorder in the Australian community

2014 ◽  
Vol 49 (3) ◽  
pp. 227-235 ◽  
Author(s):  
Erica Crome ◽  
Rachel Grove ◽  
Andrew J Baillie ◽  
Matthew Sunderland ◽  
Maree Teesson ◽  
...  
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Dsm 5 ◽  
Australian Community ◽  
Dsm Iv

scholarly journals A cognitive-behavior therapy applied to a social anxiety disorder and a specific phobia, case study

2014 ◽  
Vol 2 (3) ◽  
Author(s):  
George D. Tsitsas ◽  
Antonia A. Paschali
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Tall Buildings ◽  
Specific Phobia ◽  
Panic Attacks ◽  
Cognitive Behavior ◽  
University Counseling

George, a 23-year-old Greek student, was referred by a psychiatrist for treatment to a University Counseling Centre in Athens. He was diagnosed with social anxiety disorder and specific phobia situational type. He was complaining of panic attacks and severe symptoms of anxiety. These symptoms were triggered when in certain social situations and also when travelling by plane, driving a car and visiting tall buildings or high places. His symptoms lead him to avoid finding himself in such situations, to the point that it had affected his daily life. George was diagnosed with social anxiety disorder and with specific phobia, situational type (in this case acrophobia) and was given 20 individual sessions of cognitive-behavior therapy. Following therapy, and follow-up occurring one month post treatment, George no longer met the criteria for social phobia and symptoms leading to acrophobia were reduced. He demonstrated improvements in many areas including driving a car in and out of Athens and visiting tall buildings.

Sign in / Sign up

Export Citation Format

Share Document